You have 9 free searches left this month | for more free features.

Ovarian cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    Transforming Ovarian Cancer Diagnostic Pathways

    Not yet recruiting
    • Ovarian Cancer
      • Birmingham, United Kingdom
      • +2 more
      Nov 10, 2023

      Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

      Not yet recruiting
      • Serous Ovarian Cancer
      • Advanced Ovarian Cancer
      • (no location specified)
      Sep 20, 2023

      Early Screening of Epithelial Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • Fragmentomics
      • (no location specified)
      Jun 26, 2023

      Total Management of Ovarian Cancer

      Not yet recruiting
      • Tumor of Female Reproductive System
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 30, 2023

      Epithelial Ovarian Cancer: A Retrospective Study

      Recruiting
      • Epithelial Ovarian Cancer
      • Hematologic features
      • Shanghai, Shanghai, China
        Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
      Oct 16, 2023

      Platinum-resistant Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • pegylated liposomal doxorubicin
      • (no location specified)
      Aug 2, 2023

      Ovarian Cancer Trial in Helsinki (Biomolecular profiling)

      Recruiting
      • Ovarian Cancer
      • Biomolecular profiling
      • Helsinki, Finland
        Helsinki University and Helsinki University Hospital
      Nov 1, 2023

      Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

      Not yet recruiting
      • Ovarian Cancer Recurrent
      • Fluzopril Combined With Apatinib
      • (no location specified)
      Oct 22, 2023

      Metabolic Biomarkers and Their Prognostic Relationship in

      Not yet recruiting
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 24, 2023

      Ovarian Cancer Trial in France (tests to determine HRD status)

      Not yet recruiting
      • Ovarian Cancer
      • tests to determine HRD status
      • Amiens, France
      • +3 more
      Nov 22, 2023

      Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

      Not yet recruiting
      • Ovarian Cancer Stage III
      • Ovarian Cancer Stage IV
      • Artificial Intelligence
      • (no location specified)
      Aug 24, 2023

      ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

      Recruiting
      • Ovarian Cancer Stage IV
      • Ovarian Cancer Stage III
        • Guangzhou, Guangdong, China
          Sun Yat-Sen Memorial Hospital
        Aug 30, 2023

        Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

        Active, not recruiting
        • Ovarian Cancer
        • Platinum-resistant Ovarian Cancer
        • Minsk, Belarus
          Minsk City Clinical Oncology Center
        Jul 27, 2023

        Ovarian Cancer Trial in Roma (Blood sample)

        Recruiting
        • Ovarian Cancer
        • Blood sample
        • Roma, Italy
          Policlinico Universitario Agostino Gemelli
        Oct 10, 2023

        Participation Patterns Among Recurrent Ovarian Cancer Patients

        Not yet recruiting
        • Recurrent Ovarian Cancer
          • San Francisco, California
            Power Life Sciences
          Sep 30, 2023

          Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

          Not yet recruiting
          • Ovarian Cancer
          • +3 more
          • Toronto, Ontario, Canada
            Sunnybrook Research Institute
          Jul 18, 2023

          Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

          Not yet recruiting
          • Ovarian Cancer
          • Olaparib tablet
          • Pittsburgh, Pennsylvania
            UPMC Hillman Cancer Center
          Nov 1, 2023

          Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

          Not yet recruiting
          • Ovarian Cancer
          • +3 more
          • Beijing, Beijing, China
            Lingying Wu
          Aug 22, 2023

          68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

          Not yet recruiting
          • 68Ga-FAPI
          • +3 more
          • 68Ga-FAPI
          • Shanghai, Shanghai, China
            Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
          May 3, 2023

          A Prospective, Randomized Controlled Study of Cyclophosphamide,

          Not yet recruiting
          • Epithelial Ovarian Cancer
          • Shijiazhuang, Hebei, China
            Hebei
          Aug 20, 2023

          Ovarian Cancer Trial in Rome (Tumor and blood sample)

          Recruiting
          • Ovarian Cancer
          • Tumor and blood sample
          • Rome, Italy
            Fondazione Policlinico Universitario Agostino Gemelli IRCCS
          Jul 18, 2023

          Ovarian Cancer Trial in Padova (Laparoscopic Debulking Surgery in advanced ovarian cancer, Standard laparotomic Debulking

          Recruiting
          • Ovarian Cancer
          • Laparoscopic Debulking Surgery in advanced ovarian cancer
          • Standard laparotomic Debulking Surgery in advanced ovarian cancer
          • Padova, Padova, Veneto, Italy
            Azienda Ospedaliera Universitaria di Padova,
          May 8, 2023

          Appraising Medical Trial Experiences of Ovarian Cancer Patients

          Not yet recruiting
          • Ovarian Cancer
            • (no location specified)
            Mar 24, 2023

            Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

            Not yet recruiting
            • Ovarian Cancer
            • +4 more
            • (no location specified)
            May 12, 2023